Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Candida albicans Augments Staphylococcus aureus Virulence by Engaging the Staphylococcal agr Quorum Sensing System.

Todd OA, Fidel PL Jr, Harro JM, Hilliard JJ, Tkaczyk C, Sellman BR, Noverr MC, Peters BM.

MBio. 2019 Jun 4;10(3). pii: e00910-19. doi: 10.1128/mBio.00910-19.

2.

Spectrum of Trained Innate Immunity Induced by Low Virulence Candida Species Against Lethal Polymicrobial Intra-Abdominal Infection.

Lilly EA, Yano J, Esher SK, Hardie E, Fidel PL Jr, Noverr MC.

Infect Immun. 2019 May 13. pii: IAI.00348-19. doi: 10.1128/IAI.00348-19. [Epub ahead of print]

3.

Candida/Staphylococcal Polymicrobial Intra-Abdominal Infection: Pathogenesis and Perspectives for a Novel Form of Trained Innate Immunity.

Esher SK, Fidel PL Jr, Noverr MC.

J Fungi (Basel). 2019 May 9;5(2). pii: E37. doi: 10.3390/jof5020037. Review.

4.

Questions remain regarding the presence of fungal species biofilm in women with vulvovaginal candidiasis.

Noverr MC, Fidel PL Jr.

Am J Obstet Gynecol. 2019 Apr 25. pii: S0002-9378(19)30582-4. doi: 10.1016/j.ajog.2019.04.017. [Epub ahead of print] No abstract available.

PMID:
31029662
5.

Candida glabrata Has No Enhancing Role in the Pathogenesis of Candida-Associated Denture Stomatitis in a Rat Model.

Yano J, Yu A, Fidel PL Jr, Noverr MC.

mSphere. 2019 Apr 3;4(2). pii: e00191-19. doi: 10.1128/mSphere.00191-19.

6.

Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes.

Yano J, Sobel JD, Nyirjesy P, Sobel R, Williams VL, Yu Q, Noverr MC, Fidel PL Jr.

BMC Womens Health. 2019 Mar 29;19(1):48. doi: 10.1186/s12905-019-0748-8.

7.
8.

Immune Protection against Lethal Fungal-Bacterial Intra-Abdominal Infections.

Lilly EA, Ikeh M, Nash EE, Fidel PL Jr, Noverr MC.

MBio. 2018 Jan 16;9(1). pii: e01472-17. doi: 10.1128/mBio.01472-17.

9.

Prostaglandin E2 Receptor Antagonist with Antimicrobial Activity against Methicillin-Resistant Staphylococcus aureus.

Ikeh MAC, Fidel PL Jr, Noverr MC.

Antimicrob Agents Chemother. 2018 Feb 23;62(3). pii: e01920-17. doi: 10.1128/AAC.01920-17. Print 2018 Mar.

10.

Novel Mechanism behind the Immunopathogenesis of Vulvovaginal Candidiasis: "Neutrophil Anergy".

Yano J, Peters BM, Noverr MC, Fidel PL Jr.

Infect Immun. 2018 Feb 20;86(3). pii: e00684-17. doi: 10.1128/IAI.00684-17. Print 2018 Mar. Review.

11.

Fungal interactions with the human host: exploring the spectrum of symbiosis.

Hall RA, Noverr MC.

Curr Opin Microbiol. 2017 Dec;40:58-64. doi: 10.1016/j.mib.2017.10.020. Epub 2017 Nov 11. Review.

12.

Reply to "Chronic Vaginal Candidiasis Is Achievable in Outbred CD-1 Mice".

Yano J, Noverr MC, Fidel PL Jr.

MBio. 2017 Oct 24;8(5). pii: e01736-17. doi: 10.1128/mBio.01736-17. No abstract available.

13.
14.

Synthesis, Antifungal Activity, and Biocompatibility of Novel 1,4-Diazabicyclo[2.2.2]Octane (DABCO) Compounds and DABCO-Containing Denture Base Resins.

Herman JL, Wang Y, Lilly EA, Lallier TE, Peters BM, Hamdan S, Xu X, Fidel PL Jr, Noverr MC.

Antimicrob Agents Chemother. 2017 Mar 24;61(4). pii: e02575-16. doi: 10.1128/AAC.02575-16. Print 2017 Apr.

15.

Transcription Factors Efg1 and Bcr1 Regulate Biofilm Formation and Virulence during Candida albicans-Associated Denture Stomatitis.

Yano J, Yu A, Fidel PL Jr, Noverr MC.

PLoS One. 2016 Jul 25;11(7):e0159692. doi: 10.1371/journal.pone.0159692. eCollection 2016.

16.

An Optimized Lock Solution Containing Micafungin, Ethanol and Doxycycline Inhibits Candida albicans and Mixed C. albicans - Staphyloccoccus aureus Biofilms.

Lown L, Peters BM, Walraven CJ, Noverr MC, Lee SA.

PLoS One. 2016 Jul 18;11(7):e0159225. doi: 10.1371/journal.pone.0159225. eCollection 2016.

17.

A Murine Model of Candida glabrata Vaginitis Shows No Evidence of an Inflammatory Immunopathogenic Response.

Nash EE, Peters BM, Lilly EA, Noverr MC, Fidel PL Jr.

PLoS One. 2016 Jan 25;11(1):e0147969. doi: 10.1371/journal.pone.0147969. eCollection 2016.

18.

Morphology-Independent Virulence of Candida Species during Polymicrobial Intra-abdominal Infections with Staphylococcus aureus.

Nash EE, Peters BM, Fidel PL, Noverr MC.

Infect Immun. 2015 Oct 19;84(1):90-8. doi: 10.1128/IAI.01059-15. Print 2016 Jan.

19.

ERG2 and ERG24 Are Required for Normal Vacuolar Physiology as Well as Candida albicans Pathogenicity in a Murine Model of Disseminated but Not Vaginal Candidiasis.

Luna-Tapia A, Peters BM, Eberle KE, Kerns ME, Foster TP, Marrero L, Noverr MC, Fidel PL Jr, Palmer GE.

Eukaryot Cell. 2015 Oct;14(10):1006-16. doi: 10.1128/EC.00116-15. Epub 2015 Jul 31.

20.

Transcriptomic analysis of vulvovaginal candidiasis identifies a role for the NLRP3 inflammasome.

Bruno VM, Shetty AC, Yano J, Fidel PL Jr, Noverr MC, Peters BM.

MBio. 2015 Apr 21;6(2). pii: e00182-15. doi: 10.1128/mBio.00182-15.

21.

xCT, not just an amino-acid transporter: a multi-functional regulator of microbial infection and associated diseases.

Dai L, Noverr MC, Parsons C, Kaleeba JA, Qin Z.

Front Microbiol. 2015 Feb 19;6:120. doi: 10.3389/fmicb.2015.00120. eCollection 2015.

22.

Lipoteichoic acid (LTA) and lipopolysaccharides (LPS) from periodontal pathogenic bacteria facilitate oncogenic herpesvirus infection within primary oral cells.

Dai L, DeFee MR, Cao Y, Wen J, Wen X, Noverr MC, Qin Z.

PLoS One. 2014 Jun 27;9(6):e101326. doi: 10.1371/journal.pone.0101326. eCollection 2014.

23.

Morphogenesis is not required for Candida albicans-Staphylococcus aureus intra-abdominal infection-mediated dissemination and lethal sepsis.

Nash EE, Peters BM, Palmer GE, Fidel PL, Noverr MC.

Infect Immun. 2014 Aug;82(8):3426-35. doi: 10.1128/IAI.01746-14. Epub 2014 Jun 2.

24.

Candida vaginitis: when opportunism knocks, the host responds.

Peters BM, Yano J, Noverr MC, Fidel PL Jr.

PLoS Pathog. 2014 Apr 3;10(4):e1003965. doi: 10.1371/journal.ppat.1003965. eCollection 2014 Apr. Review. No abstract available.

25.

Fungal morphogenetic pathways are required for the hallmark inflammatory response during Candida albicans vaginitis.

Peters BM, Palmer GE, Nash AK, Lilly EA, Fidel PL Jr, Noverr MC.

Infect Immun. 2014 Feb;82(2):532-43. doi: 10.1128/IAI.01417-13. Epub 2013 Nov 11.

26.

The emerging world of the fungal microbiome.

Huffnagle GB, Noverr MC.

Trends Microbiol. 2013 Jul;21(7):334-41. doi: 10.1016/j.tim.2013.04.002. Epub 2013 May 17. Review.

27.

Candida albicans-Staphylococcus aureus polymicrobial peritonitis modulates host innate immunity.

Peters BM, Noverr MC.

Infect Immun. 2013 Jun;81(6):2178-89. doi: 10.1128/IAI.00265-13. Epub 2013 Apr 1.

28.

Efficacy of ethanol against Candida albicans and Staphylococcus aureus polymicrobial biofilms.

Peters BM, Ward RM, Rane HS, Lee SA, Noverr MC.

Antimicrob Agents Chemother. 2013 Jan;57(1):74-82. doi: 10.1128/AAC.01599-12. Epub 2012 Oct 15.

29.

Development of a contemporary animal model of Candida albicans-associated denture stomatitis using a novel intraoral denture system.

Johnson CC, Yu A, Lee H, Fidel PL Jr, Noverr MC.

Infect Immun. 2012 May;80(5):1736-43. doi: 10.1128/IAI.00019-12. Epub 2012 Mar 5.

30.

Cytokines in the host response to Candida vaginitis: Identifying a role for non-classical immune mediators, S100 alarmins.

Yano J, Noverr MC, Fidel PL Jr.

Cytokine. 2012 Apr;58(1):118-28. doi: 10.1016/j.cyto.2011.11.021. Epub 2011 Dec 17. Review.

31.

Importance of Candida-bacterial polymicrobial biofilms in disease.

Harriott MM, Noverr MC.

Trends Microbiol. 2011 Nov;19(11):557-63. doi: 10.1016/j.tim.2011.07.004. Epub 2011 Aug 19. Review.

32.

Fabrication of a multi-applicable removable intraoral denture system for rodent research.

Lee H, Yu A, Johnson CC, Lilly EA, Noverr MC, Fidel PL Jr.

J Oral Rehabil. 2011 Sep;38(9):686-90. doi: 10.1111/j.1365-2842.2011.02206.x. Epub 2011 Feb 17.

33.

Exposure to host or fungal PGE₂ abrogates protection following immunization with Candida-pulsed dendritic cells.

Kundu G, Noverr MC.

Med Mycol. 2011 May;49(4):380-94. doi: 10.3109/13693786.2010.532514. Epub 2010 Nov 15.

PMID:
21077736
34.

Candida albicans forms biofilms on the vaginal mucosa.

Harriott MM, Lilly EA, Rodriguez TE, Fidel PL, Noverr MC.

Microbiology. 2010 Dec;156(Pt 12):3635-3644. doi: 10.1099/mic.0.039354-0. Epub 2010 Aug 12.

35.

Ability of Candida albicans mutants to induce Staphylococcus aureus vancomycin resistance during polymicrobial biofilm formation.

Harriott MM, Noverr MC.

Antimicrob Agents Chemother. 2010 Sep;54(9):3746-55. doi: 10.1128/AAC.00573-10. Epub 2010 Jun 21.

36.

Candida albicans and Staphylococcus aureus form polymicrobial biofilms: effects on antimicrobial resistance.

Harriott MM, Noverr MC.

Antimicrob Agents Chemother. 2009 Sep;53(9):3914-22. doi: 10.1128/AAC.00657-09. Epub 2009 Jun 29.

37.

The "Microflora Hypothesis" of allergic disease.

Shreiner A, Huffnagle GB, Noverr MC.

Adv Exp Med Biol. 2008;635:113-34. doi: 10.1007/978-0-387-09550-9_10. Review.

PMID:
18841708
38.

Overview of gut immunology.

Mason KL, Huffnagle GB, Noverr MC, Kao JY.

Adv Exp Med Biol. 2008;635:1-14. doi: 10.1007/978-0-387-09550-9_1. Review.

PMID:
18841699
39.

GI microbiota and regulation of the immune system. Preface.

Huffnagle G, Noverr MC.

Adv Exp Med Biol. 2008;635:v-vi. No abstract available.

PMID:
18841698
40.

Characterization of prostaglandin E2 production by Candida albicans.

Erb-Downward JR, Noverr MC.

Infect Immun. 2007 Jul;75(7):3498-505. Epub 2007 Apr 30.

41.

The 'microflora hypothesis' of allergic diseases.

Noverr MC, Huffnagle GB.

Clin Exp Allergy. 2005 Dec;35(12):1511-20. Review.

42.
43.

Does the microbiota regulate immune responses outside the gut?

Noverr MC, Huffnagle GB.

Trends Microbiol. 2004 Dec;12(12):562-8. Review.

PMID:
15539116
44.

Regulation of Candida albicans morphogenesis by fatty acid metabolites.

Noverr MC, Huffnagle GB.

Infect Immun. 2004 Nov;72(11):6206-10.

45.

Role of antibiotics and fungal microbiota in driving pulmonary allergic responses.

Noverr MC, Noggle RM, Toews GB, Huffnagle GB.

Infect Immun. 2004 Sep;72(9):4996-5003.

46.

Urease expression by Cryptococcus neoformans promotes microvascular sequestration, thereby enhancing central nervous system invasion.

Olszewski MA, Noverr MC, Chen GH, Toews GB, Cox GM, Perfect JR, Huffnagle GB.

Am J Pathol. 2004 May;164(5):1761-71.

47.

CNLAC1 is required for extrapulmonary dissemination of Cryptococcus neoformans but not pulmonary persistence.

Noverr MC, Williamson PR, Fajardo RS, Huffnagle GB.

Infect Immun. 2004 Mar;72(3):1693-9.

48.

Production of eicosanoids and other oxylipins by pathogenic eukaryotic microbes.

Noverr MC, Erb-Downward JR, Huffnagle GB.

Clin Microbiol Rev. 2003 Jul;16(3):517-33. Review.

49.

Role of PLB1 in pulmonary inflammation and cryptococcal eicosanoid production.

Noverr MC, Cox GM, Perfect JR, Huffnagle GB.

Infect Immun. 2003 Mar;71(3):1538-47.

50.

Production of prostaglandins and leukotrienes by pathogenic fungi.

Noverr MC, Toews GB, Huffnagle GB.

Infect Immun. 2002 Jan;70(1):400-2.

Supplemental Content

Loading ...
Support Center